A private equity and venture capital firm in Massachusetts that focuses on commercial development of advanced technology in life sciences and healthcare.
Bioventures Investors is a private equity and in Massachusetts that focuses on commercial development of advanced technology in life sciences and healthcare. Founded 1998 in , by Marc Goldberg, it invests in early stage ventures and late stage ventures. Its portfolio companies include Sonomotion, Kanova, , POC Medical Systems, Nano-Micro Technology, , Claros Diagnostics, , and . As of March 2020, Bioventures Investors has made 32 investments. Their most recent investment was on November 12, 2019, when Sonomotion raised $10M. Bioventures Investors has had seven exits, the most notable of which include Enanta Pharmaceuticals, , and Spirus Medical. The company has raised a single venture fund, BioVentures Investors IV. This fund was announced on October 10, 2016 and raised a total of $87M.